4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-004420
Chief Executive Officer sold 3,236 shares at $5.13 ($16,616)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2020-01-14 | Sale | −3,236 | $5.13 | $16,616 | 3,166 | D |
| Open-market sales · 3,236 sh · avg $5.13 · $16,616 | |||||||
Loading xslF345X03/a4.xml…